Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 5/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.51 |
| ▸ | MMP9 | P14780 | 1/20 | 0.50 |
| ▸ | MMP8 | P22894 | 1/20 | 0.50 |
| ▸ | MMP14 | P50281 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 4/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | ATM | Q13315 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 3/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.38 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20725831 | 1.00 | CYP3A4 (0.67) | CYP3A4ALDH1A1MMP9MMP8MMP14 | |
| SCHEMBL3765751 | 0.96 | CYP3A4 (0.71) | CYP3A4ALDH1A1MMP9MMP8MMP14 | |
| SCHEMBL1839353 | 0.96 | CYP3A4 (0.71) | CYP3A4ALDH1A1MMP9MMP8MMP14 | |
| SCHEMBL11905467 | 0.96 | CYP3A4 (0.71) | CYP3A4ALDH1A1MMP9MMP8MMP14 | |
| SCHEMBL13007628 | 0.96 | CYP3A4 (0.71) | CYP3A4ALDH1A1MMP9MMP8MMP14 | |
| SCHEMBL3432858 | 0.96 | CYP3A4 (0.71) | CYP3A4ALDH1A1MMP9MMP8MMP14 | |
| SCHEMBL13007629 | 0.96 | CYP3A4 (0.71) | CYP3A4ALDH1A1MMP9MMP8MMP14 | |
| Ammonia Solution, Strong SCHEMBL1789569 | 0.94 | CYP3A4 (0.69) | CYP3A4ALDH1A1MMP9MMP8MMP14 | |
| SCHEMBL1835296 | 0.94 | CYP3A4 (0.74) | CYP3A4ALDH1A1MMP9MMP8MMP14 | |
| Ethylene SCHEMBL15254964 | 0.92 | CYP3A4 (0.67) | CYP3A4ALDH1A1MMP9MMP8MMP14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11693310-B2 | Blue curable resin composition, blue color filter, and display device including same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-07-04 | — | — | US | disclosed |
| EP-2809734-B1 | INKJET INK AND INKJET RECORDING DEVICE | RICOH CO LTD (JP) | 2017-10-18 | — | — | EP | disclosed |
| US-9528017-B2 | Inkjet ink and inkjet recording device | RICOH COMPANY, LTD. (JP) | 2016-12-27 | — | — | US | disclosed |
| US-9051397-B2 | Oxime ester | BASF SE (DE) | 2015-06-09 | — | — | US | disclosed |
| US-9051397-B2 | Oxime ester | BASF SE (DE) | 2015-06-09 | — | — | US | disclosed |
| US-20140368572-A1 | INKJET INK AND INKJET RECORDING DEVICE | RICOH COMPANY, LTD. (JP) | 2014-12-18 | — | — | US | disclosed |
| EP-2625166-B1 | OXIME ESTER DERIVATIVES OF BENZOCARBAZOLE COMPOUNDS AND THEIR USE AS PHOTOINITIATORS IN PHOTOPOLYMERIZABLE COMPOSITIONS | BASF SE (DE) | 2014-09-24 | — | — | EP | disclosed |
| WO-2013115344-A1 | INKJET INK AND INKJET RECORDING DEVICE | RICOH COMPANY, LTD. (JP) | 2013-08-08 | — | — | WO | disclosed |
| US-20130188270-A1 | OXIME ESTER | BASF SE (DE) | 2013-07-25 | — | — | US | disclosed |
| US-20130188270-A1 | OXIME ESTER | BASF SE (DE) | 2013-07-25 | — | — | US | disclosed |
| WO-2012045736-A1 | OXIME ESTER DERIVATIVES OF BENZOCARBAZOLE COMPOUNDS AND THEIR USE AS PHOTOINITIATORS IN PHOTOPOLYMERIZABLE COMPOSITIONS | BASF SE (DE) | 2012-04-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130188270-A1 | OXIME ESTER | CBR3, CBR1, COX15 | CYP3A4 156/4885ALDH1A1 738/4885MMP9 3508/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.